These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31479092)

  • 21. Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
    Zeglis BM; Davis CB; Abdel-Atti D; Carlin SD; Chen A; Aggeler R; Agnew BJ; Lewis JS
    Bioconjug Chem; 2014 Dec; 25(12):2123-8. PubMed ID: 25418333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and testing of engineered multimeric Fabs of trastuzumab.
    Selis F; Sandomenico A; Cantile M; Sanna R; Calvanese L; Falcigno L; Dell'Omo P; Esperti A; De Falco S; Focà A; Caporale A; Iaccarino E; Truppo E; Scaramuzza S; Tonon G; Ruvo M
    Int J Biol Macromol; 2020 Dec; 164():4516-4531. PubMed ID: 32941911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors.
    Adumeau P; Raavé R; Boswinkel M; Heskamp S; Wessels HJCT; van Gool AJ; Moreau M; Bernhard C; Da Costa L; Goncalves V; Denat F
    Bioconjug Chem; 2022 Mar; 33(3):530-540. PubMed ID: 35230093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
    Zhou Q; Kim J
    Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours.
    Knight JC; Mosley MJ; Kersemans V; Dias GM; Allen PD; Smart S; Cornelissen B
    Nucl Med Biol; 2019 Mar; 70():14-22. PubMed ID: 30825614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Apr; 18(2):153-65. PubMed ID: 26754791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Next-Generation Maleimides (NGMs) to Site-Selective Antibody Conjugation.
    Morais M; Forte N; Chudasama V; Baker JR
    Methods Mol Biol; 2019; 2033():15-24. PubMed ID: 31332744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates.
    Sarrett SM; Rodriguez C; Rymarczyk G; Hosny MM; Keinänen O; Delaney S; Thau S; Krantz BA; Zeglis BM
    Bioconjug Chem; 2022 Sep; 33(9):1750-1760. PubMed ID: 35946495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate Design Enables Heterobifunctional, Dual "Click" Antibody Modification via Microbial Transglutaminase.
    Walker JA; Bohn JJ; Ledesma F; Sorkin MR; Kabaria SR; Thornlow DN; Alabi CA
    Bioconjug Chem; 2019 Sep; 30(9):2452-2457. PubMed ID: 31409067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability.
    Adumeau P; Davydova M; Zeglis BM
    Bioconjug Chem; 2018 Apr; 29(4):1364-1372. PubMed ID: 29509393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
    Harrington BS; He Y; Khan T; Puttick S; Conroy PJ; Kryza T; Cuda T; Sokolowski KA; Tse BW; Robbins KK; Arachchige BJ; Stehbens SJ; Pollock PM; Reed S; Weroha SJ; Haluska P; Salomon C; Lourie R; Perrin LC; Law RHP; Whisstock JC; Hooper JD
    Theranostics; 2020; 10(5):2095-2114. PubMed ID: 32104500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates.
    Puthenveetil S; Musto S; Loganzo F; Tumey LN; O'Donnell CJ; Graziani E
    Bioconjug Chem; 2016 Apr; 27(4):1030-9. PubMed ID: 26942771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates.
    Zhang X; Ou C; Liu H; Prabhu SK; Li C; Yang Q; Wang LX
    ACS Chem Biol; 2021 Nov; 16(11):2502-2514. PubMed ID: 34569782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
    Shen BQ; Xu K; Liu L; Raab H; Bhakta S; Kenrick M; Parsons-Reponte KL; Tien J; Yu SF; Mai E; Li D; Tibbitts J; Baudys J; Saad OM; Scales SJ; McDonald PJ; Hass PE; Eigenbrot C; Nguyen T; Solis WA; Fuji RN; Flagella KM; Patel D; Spencer SD; Khawli LA; Ebens A; Wong WL; Vandlen R; Kaur S; Sliwkowski MX; Scheller RH; Polakis P; Junutula JR
    Nat Biotechnol; 2012 Jan; 30(2):184-9. PubMed ID: 22267010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies.
    Yamada K; Shikida N; Shimbo K; Ito Y; Khedri Z; Matsuda Y; Mendelsohn BA
    Angew Chem Int Ed Engl; 2019 Apr; 58(17):5592-5597. PubMed ID: 30854738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal α-amino group modification of antibodies using a site-selective click chemistry method.
    Li DZ; Han BN; Wei R; Yao GY; Chen Z; Liu J; Poon TCW; Su W; Zhu Z; Dimitrov DS; Zhao Q
    MAbs; 2018 Jul; 10(5):712-719. PubMed ID: 29652547
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Pandya DN; Bhatt NB; Almaguel F; Rideout-Danner S; Gage HD; Solingapuram Sai KK; Wadas TJ
    J Nucl Med; 2019 May; 60(5):696-701. PubMed ID: 30442753
    [No Abstract]   [Full Text] [Related]  

  • 39. Robust Strategy for Antibody-Polymer-Drug Conjugation: Significance of Conjugating Orientation and Linker Charge on Targeting Ability.
    Wan J; Li Y; Jin K; Guo J; Xu J; Wang C
    ACS Appl Mater Interfaces; 2020 May; 12(21):23717-23725. PubMed ID: 32368886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug Conjugates.
    Hwang D; Tsuji K; Park H; Burke TR; Rader C
    Bioconjug Chem; 2019 Nov; 30(11):2889-2896. PubMed ID: 31675216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.